Innova Captab (BOM:544067) OCF Margin %: 0.00% (As of Mar. 2026)


BOM:544067 Innova Captab Ltd BOM:544067
45 GF Score
Price ₹956.50
! 6 Warning Signs
View Full Analysis

What is Innova Captab OCF Margin %?

Innova Captab BOM:544067 -2.34% 45 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates BOM:544067 with a GF Score™ of 45/100. The stock has 6 warning signs investors should review. Among 961 Drug Manufacturers companies, Innova Captab ranks worse than 56.3% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Innova Captab's Cash Flow from Operations for the three months ended in Mar. 2026 was ₹0 Mil. Innova Captab's Revenue for the three months ended in Mar. 2026 was ₹4,478 Mil. Therefore, Innova Captab's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Innova Captab's current OCF Yield % is 2.16%.

The historical rank and industry rank for Innova Captab's OCF Margin % or its related term are showing as below:

BOM:544067' s OCF Margin % Range Over the Past 10 Years
Min: 3.82   Med: 7.26   Max: 13.59
Current: 7.15

During the past 8 years, the highest OCF Margin % of Innova Captab was 13.59%. The lowest was 3.82%. And the median was 7.26%.

BOM:544067's OCF Margin % is ranked worse than
56.3% of 961 companies
in the Drug Manufacturers industry
Industry Median: 9.94 vs BOM:544067: 7.15

Innova Captab OCF Margin % Related Terms

Innova Captab OCF Margin % Historical Data

* Premium members only.

The historical data trend for Innova Captab's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innova Captab OCF Margin % Chart

Innova Captab Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial 7.36 7.25 13.59 5.17 7.26

Innova Captab Quarterly Data
Mar19 Mar20 Mar21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:544067 vs ZTS, UTHR: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Innova Captab's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innova Captab OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Innova Captab's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Innova Captab's OCF Margin % falls into.


BOM:544067
45GF Score
Innova Captab Ltd BOM:544067
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innova Captab OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Innova Captab's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=1165.15/16039.07
=7.26 %

Innova Captab's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/4478.02
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Innova Captab (BOM:544067) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Innova Captab and its competitors. Over the past decade, Innova Captab's OCF Margin % has ranged from 3.82 to 13.59. According to the industry distribution chart, Innova Captab ranks #541 out of 961 companies in the Drug Manufacturers industry, placing it in the top 56.3%.
Is Innova Captab's OCF Margin % too high?
Innova Captab's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 3.82 to a high of 13.59. Based on the distribution chart, Innova Captab ranks #541 out of 961 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Innova Captab has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Innova Captab's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Innova Captab ranks #541 out of 961 companies for OCF Margin %. This places Innova Captab in the lower half of its industry. The industry median OCF Margin % is 9.94. Historically, Innova Captab's own OCF Margin % has ranged from 3.82 to 13.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Innova Captab and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innova Captab's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innova Captab stock overvalued right now?
Innova Captab (BOM:544067) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Innova Captab's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Innova Captab (BOM:544067), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innova Captab Business Description

Other Exchanges INNOVACAP:India
Address Plot No.320, Industrial Area, Phase-1, Panchkula, HR, IND, 134113
Innova Captab Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has identified "Drugs and pharmaceutical products" as single operating segment. The company has presence in India, and Outside India. The company generates majority of revenue from India. The company's products are Cephalosporins, Proton Pump Inhibitor, Antocholinergic and Heparin NSAIDs, Analgesics and Antipyretic, Anticold and Antiallergic, Antiemetic, Antidiabetic, Antispasmodic, Antifibrinolytic, Cardiovascular, Antioxidant and Vitamins, Antihyperuricemia and Antigout, Fluoroquinolone and Macrolide, Nootropics and Neurotonics/ Neurotrophics, Antiulcerative, Antimalarial Anxiolytic, Anticonvulsant and Antipsychotic, Bladder and Prostate Disorder, etc.
45GF Score

Get the complete analysis for BOM:544067

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹956.50
Price